Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

AIM: To evaluate the impact of sodium glucose cotransporter 2 inhibitors (SGLT-2i) on risk of heart failure hospitalization in patients with type 2 diabetes. METHODS: We searched the PubMed, Embase, The Cochrane Library, CNKI, Wanfang, CBM, and other web knowledge databases for data from randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ailing, Luo, Xufei, Meng, Haiyang, Kang, Jian, Qin, Guijun, Chen, Yaolong, Zhang, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843571/
https://www.ncbi.nlm.nih.gov/pubmed/33519713
http://dx.doi.org/10.3389/fendo.2020.604250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843571/
https://www.ncbi.nlm.nih.gov/pubmed/33519713
http://dx.doi.org/10.3389/fendo.2020.604250

Ejemplares similares